Skip to main content

Aurora Therapeutics

Cambridge, United States

Aurora Therapeutics is changing the way personalized gene-editing medications are created and approved for patients with rare diseases.

$16.0M raised
Jan 2026
Seed

Top Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aurora Therapeutics

How much funding has Aurora Therapeutics raised?
Aurora Therapeutics has raised $16.0M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Who are Aurora Therapeutics's investors?
Aurora Therapeutics's investors include Menlo Ventures.
Where is Aurora Therapeutics headquartered?
Aurora Therapeutics is headquartered in Cambridge, United States.
What does Aurora Therapeutics do?
Aurora Therapeutics is changing the way personalized gene-editing medications are created and approved for patients with rare diseases.
What stage is Aurora Therapeutics at?
Aurora Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aurora Therapeutics — Funding & Investors." VCBacked, January 9, 2026, https://www.vcbacked.co/company/aurora-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Aurora Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aurora-therapeutics
Wikipedia (cite web)
{{cite web |title=Aurora Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aurora-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .